Drug Information

Drug General Information
Drug ID
D0B1WB
Former ID
DNC010719
Drug Name
(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530788]
Formula
C14H29NO3
Canonical SMILES
CCCCCCCCCC1C(C(C(CN1)O)O)O
InChI
1S/C14H29NO3/c1-2-3-4-5-6-7-8-9-11-13(17)14(18)12(16)10-15-11/h11-18H,2-10H2,1H3/t11-,12-,13+,14+/m1/s1
InChIKey
WVYPOMDXOXCTJU-MQYQWHSLSA-N
PubChem Compound ID
11988371
Target and Pathway
Target(s) Glucosylceramidase Target Info Inhibitor [530788]
KEGG Pathway Other glycan degradation
Sphingolipid metabolism
Metabolic pathways
Lysosome
PathWhiz Pathway Sphingolipid Metabolism
Reactome Glycosphingolipid metabolism
WikiPathways Sphingolipid metabolism
References
Ref 530788Bioorg Med Chem. 2010 Apr 1;18(7):2645-50. Epub 2010 Feb 20.Synthesis of new beta-1-C-alkylated imino-L-iditols: A comparative study of their activity as beta-glucocerebrosidase inhibitors.
Ref 530788Bioorg Med Chem. 2010 Apr 1;18(7):2645-50. Epub 2010 Feb 20.Synthesis of new beta-1-C-alkylated imino-L-iditols: A comparative study of their activity as beta-glucocerebrosidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.